Form D · Other Health Care
Planet Biopharmaceuticals, Inc.
Danbury, CT · CIK 0001501507
Offering snapshot reported Sep 17, 2010 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.66M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Aug 31, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 17, 2010 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05, 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147909
Source: Form D, filed Sep 17, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Cole | Director |
| Francesca Di Nota | Director, Executive |
| Scott Glenn | Director |
| William Goldberg | Director, Executive |
| Andrew Schiff | Director |
| Brett Zbar | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
22 Shelter Rock Lane, Unit 51
Danbury, CT, 06810
Danbury, CT, 06810